These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1619566)

  • 1. Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans.
    Bressolle F; Brès J; Fauré-Jeantis A
    J Pharm Sci; 1992 Jan; 81(1):26-32. PubMed ID: 1619566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations.
    Brès J; Bressolle F
    J Pharm Sci; 1991 Dec; 80(12):1119-24. PubMed ID: 1815069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
    Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
    Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man.
    Flesch G; Müller P; Lloyd P
    Eur J Clin Pharmacol; 1997; 52(2):115-20. PubMed ID: 9174680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption behavior of sulpiride described using Weibull functions.
    Rietbrock S; Merz PG; Fuhr U; Harder S; Marschner JP; Loew D; Biehl J
    Int J Clin Pharmacol Ther; 1995 May; 33(5):299-303. PubMed ID: 7655770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.
    Bressolle F; Brès J; Mourad G
    Clin Pharmacokinet; 1989 Nov; 17(5):367-73. PubMed ID: 2582694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulpiride pharmacokinetics in humans after intramuscular administration at three dose levels.
    Bressolle F; Bres J; Blanchin MD; Gomeni R
    J Pharm Sci; 1984 Aug; 73(8):1128-36. PubMed ID: 6491918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteers.
    Helmy SA
    Biopharm Drug Dispos; 2013 Jul; 34(5):288-301. PubMed ID: 23585286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of sulpiride after oral and intravenous administration in the rat and the dog.
    Segura J; Borja L; Bakke OM
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):88-95. PubMed ID: 999405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal absorption of sulpiride in rat.
    Mizuno N; Morita E; Nishikata M; Shinkuma D; Yamanaka Y
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):30-8. PubMed ID: 3800511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.
    Zhang X; Nieforth K; Lang JM; Rouzier-Panis R; Reynes J; Dorr A; Kolis S; Stiles MR; Kinchelow T; Patel IH
    Clin Pharmacol Ther; 2002 Jul; 72(1):10-9. PubMed ID: 12152000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
    Kim DS; Kim DW; Kim KS; Choi JS; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Jin SG; Choi HG
    Colloids Surf B Biointerfaces; 2016 Nov; 147():250-257. PubMed ID: 27518457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-site model for drug absorption.
    Plusquellec Y; Campistron G; Staveris S; Barre J; Jung L; Tillement JP; Houin G
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):225-39. PubMed ID: 3668801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of food intake on the bioavailability of sulpiride from AEA film-coated tablet having a pH-dependent dissolution characteristic in normal or drug-induced achlorhydric subjects.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):303-9. PubMed ID: 1743804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption kinetics of orally administered leucovorin calcium.
    McGuire BW; Sia LL; Haynes JD; Kisicki JC; Gutierrez ML; Stokstad EL
    NCI Monogr; 1987; (5):47-56. PubMed ID: 3501546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
    Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS
    J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.